Market Review
During February, the bond market reacted to a bevy of growth-positive economic releases, ranging from retail sales to personal income to industrial production. Moreover, the new administration's $1.9tn recovery package moved through the House and appeared to make it through the Senate largely intact. At the same time, optimism grew over the rollout of Covid vaccines.
Read moreAll eyes remained on the pandemic and policy as the new year began. An anticipated post-holiday spike in Covid infections materialized and then began to abate by midmonth. Democratic victories in Georgia increased the likelihood of additional stimulus. With positive economic releases early in the month, "risk-on" remained the preferred trade.
Read moreThe challenge in writing periodic market commentaries is often to make interesting what was essentially more of the same. Not a problem for 2020. It is difficult to overstate how extraordinary the year was. A pandemic, remote conferencing technology, and government economic policies created a sea of change that will be felt for years to come.
Read moreThe risk-on market continued largely unabated in November, sometimes bolstered by positive news and sometimes despite negative headlines. Perhaps most important to markets was the announcement of significant progress on Covid vaccines.
Read moreThe 10-year U.S. Treasury note yield had its biggest move in months, rising 20 basis points (bps) to 0.84%. Likewise, the 30-year bond yield jumped by 18 bps to 1.64%. With short rates anchored at very low rates, the 2- to 30-year yield curve slope steepened by 15 bps.
Read more